Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupuncture with electric current may help stroke survivors speak again

NCT ID NCT07684781

Symptom relief Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether adding electroacupuncture at specific acupoints (Xuanzhong and Tongli) to standard speech therapy improves language recovery in people with post-stroke aphasia. Participants receive daily electroacupuncture sessions for four weeks, plus speech therapy. The trial compares this combination to a control group receiving electroacupuncture at other points, measuring language function and quality of life over three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electroacupuncture
What this could lead to
If effective, this approach could offer a safe, non-drug way to boost language recovery after stroke.
What could go wrong
This is a small, early-stage trial with only 30 participants. Results may not apply to all patients, and the benefit over standard therapy alone is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18 to 75 years. * Diagnosis: Diagnosed with post-stroke aphasia (PSA) based on the Ministry of Health criteria or ICD-10 codes (I60-I64). * Cognitive and Functional State: Alert and able to cooperate with the treatment. * Language Assessment: Aphasia classified as moderate or mild according to the BDAE scale (scores 2-4). * Disease Duration: Stroke occurring 7 to 90 days prior to enrollment. * Language Proficiency: Native Vietnamese speaker. * Informed Consent: Must voluntarily sign the informed consent form and agree to comply with all study requirements. Exclusion Criteria: * Non-Stroke Related Aphasia: Pre-existing aphasia or aphasia not caused by a stroke. * Severe Comorbidities: Severe heart, liver, or kidney failure. * Psychiatric/Cognitive Disorders: Diagnosed dementia or other mental health conditions. * Medical Contraindications: Presence of a pacemaker. * Dermatological Conditions: Infection at the targeted acupoint sites. * Sensory Impairment: Significant hearing or visual impairment that interferes with assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-stroke aphasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aphasia communication disorder pleomorphic adenoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-stroke aphasia PSA

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Traditional medicine - University of Medicine and Pharmacy at Ho Chi Minh City

    Ho Chi Minh City, 700000, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.